The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
NGS-based RNA-seq-Global Market Insights and Sales Trends 2024
Synopsis
Factors such as the advantages of RNA-seq over microarray technology, technological advancements in RNA-seq products, increasing number of RNA-seq grants, increasing number of research activities, and rapid growth in precision medicine are driving the growth of the NGS-based RNA-seq market.
The global NGS-based RNA-seq market size is expected to reach US$ 3354.2 million by 2029, growing at a CAGR of 11.3% from 2023 to 2029. The market is mainly driven by the significant applications of NGS-based RNA-seq in various end use industries. The expanding demands from the Hospitals and Clinics, Biopharma Companies, Government Agencies and Academic and Research Organizations, are propelling NGS-based RNA-seq market. High-Throughput Sequencing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Third-Generation Sequencing Technology segment is estimated at % CAGR for the next seven-year period.
The hospitals and clinics segment is expected to register the highest growth due to the growing number of agreements between companies and hospitals for the development of advanced tests and products catering to the specific needs of hospitals and clinics.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for NGS-based RNA-seq, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global NGS-based RNA-seq market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global NGS-based RNA-seq market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, NGS-based RNA-seq sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of NGS-based RNA-seq covered in this report include Illumina, Thermo Fisher Scientific, Pacific Biosciences Of California, Qaigen, F. Hoffmann-La Roche, Agilent Technologies, Oxford Nanopore Technologies, Perkinelmer and Eurofins Scientific, etc.
The global NGS-based RNA-seq market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumina
Thermo Fisher Scientific
Pacific Biosciences Of California
Qaigen
F. Hoffmann-La Roche
Agilent Technologies
Oxford Nanopore Technologies
Perkinelmer
Eurofins Scientific
Gatc Biotech
Macrogen
Global NGS-based RNA-seq market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global NGS-based RNA-seq market, Segment by Type:
High-Throughput Sequencing
Third-Generation Sequencing Technology
Global NGS-based RNA-seq market, by Application
Hospitals and Clinics
Biopharma Companies
Government Agencies
Academic and Research Organizations
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of NGS-based RNA-seq companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Factors such as the advantages of RNA-seq over microarray technology, technological advancements in RNA-seq products, increasing number of RNA-seq grants, increasing number of research activities, and rapid growth in precision medicine are driving the growth of the NGS-based RNA-seq market.
The global NGS-based RNA-seq market size is expected to reach US$ 3354.2 million by 2029, growing at a CAGR of 11.3% from 2023 to 2029. The market is mainly driven by the significant applications of NGS-based RNA-seq in various end use industries. The expanding demands from the Hospitals and Clinics, Biopharma Companies, Government Agencies and Academic and Research Organizations, are propelling NGS-based RNA-seq market. High-Throughput Sequencing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Third-Generation Sequencing Technology segment is estimated at % CAGR for the next seven-year period.
The hospitals and clinics segment is expected to register the highest growth due to the growing number of agreements between companies and hospitals for the development of advanced tests and products catering to the specific needs of hospitals and clinics.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for NGS-based RNA-seq, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global NGS-based RNA-seq market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global NGS-based RNA-seq market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, NGS-based RNA-seq sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of NGS-based RNA-seq covered in this report include Illumina, Thermo Fisher Scientific, Pacific Biosciences Of California, Qaigen, F. Hoffmann-La Roche, Agilent Technologies, Oxford Nanopore Technologies, Perkinelmer and Eurofins Scientific, etc.
The global NGS-based RNA-seq market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumina
Thermo Fisher Scientific
Pacific Biosciences Of California
Qaigen
F. Hoffmann-La Roche
Agilent Technologies
Oxford Nanopore Technologies
Perkinelmer
Eurofins Scientific
Gatc Biotech
Macrogen
Global NGS-based RNA-seq market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global NGS-based RNA-seq market, Segment by Type:
High-Throughput Sequencing
Third-Generation Sequencing Technology
Global NGS-based RNA-seq market, by Application
Hospitals and Clinics
Biopharma Companies
Government Agencies
Academic and Research Organizations
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of NGS-based RNA-seq companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of NGS-based RNA-seq
1.1 NGS-based RNA-seq Market Overview
1.1.1 NGS-based RNA-seq Product Scope
1.1.2 NGS-based RNA-seq Market Status and Outlook
1.2 Global NGS-based RNA-seq Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global NGS-based RNA-seq Market Size by Region (2018-2029)
1.4 Global NGS-based RNA-seq Historic Market Size by Region (2018-2023)
1.5 Global NGS-based RNA-seq Market Size Forecast by Region (2024-2029)
1.6 Key Regions, NGS-based RNA-seq Market Size (2018-2029)
1.6.1 North America NGS-based RNA-seq Market Size (2018-2029)
1.6.2 Europe NGS-based RNA-seq Market Size (2018-2029)
1.6.3 Asia-Pacific NGS-based RNA-seq Market Size (2018-2029)
1.6.4 Latin America NGS-based RNA-seq Market Size (2018-2029)
1.6.5 Middle East & Africa NGS-based RNA-seq Market Size (2018-2029)
2 NGS-based RNA-seq Market by Type
2.1 Introduction
2.1.1 High-Throughput Sequencing
2.1.2 Third-Generation Sequencing Technology
2.2 Global NGS-based RNA-seq Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global NGS-based RNA-seq Historic Market Size by Type (2018-2023)
2.2.2 Global NGS-based RNA-seq Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America NGS-based RNA-seq Revenue Breakdown by Type (2018-2029)
2.3.2 Europe NGS-based RNA-seq Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific NGS-based RNA-seq Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America NGS-based RNA-seq Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa NGS-based RNA-seq Revenue Breakdown by Type (2018-2029)
3 NGS-based RNA-seq Market Overview by Application
3.1 Introduction
3.1.1 Hospitals and Clinics
3.1.2 Biopharma Companies
3.1.3 Government Agencies
3.1.4 Academic and Research Organizations
3.1.5 Other
3.2 Global NGS-based RNA-seq Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global NGS-based RNA-seq Historic Market Size by Application (2018-2023)
3.2.2 Global NGS-based RNA-seq Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America NGS-based RNA-seq Revenue Breakdown by Application (2018-2029)
3.3.2 Europe NGS-based RNA-seq Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific NGS-based RNA-seq Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America NGS-based RNA-seq Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa NGS-based RNA-seq Revenue Breakdown by Application (2018-2029)
4 NGS-based RNA-seq Competition Analysis by Players
4.1 Global NGS-based RNA-seq Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in NGS-based RNA-seq as of 2022)
4.3 Date of Key Players Enter into NGS-based RNA-seq Market
4.4 Global Top Players NGS-based RNA-seq Headquarters and Area Served
4.5 Key Players NGS-based RNA-seq Product Solution and Service
4.6 Competitive Status
4.6.1 NGS-based RNA-seq Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Illumina
5.1.1 Illumina Profile
5.1.2 Illumina Main Business
5.1.3 Illumina NGS-based RNA-seq Products, Services and Solutions
5.1.4 Illumina NGS-based RNA-seq Revenue (US$ Million) & (2018-2023)
5.1.5 Illumina Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Profile
5.2.2 Thermo Fisher Scientific Main Business
5.2.3 Thermo Fisher Scientific NGS-based RNA-seq Products, Services and Solutions
5.2.4 Thermo Fisher Scientific NGS-based RNA-seq Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific Recent Developments
5.3 Pacific Biosciences Of California
5.3.1 Pacific Biosciences Of California Profile
5.3.2 Pacific Biosciences Of California Main Business
5.3.3 Pacific Biosciences Of California NGS-based RNA-seq Products, Services and Solutions
5.3.4 Pacific Biosciences Of California NGS-based RNA-seq Revenue (US$ Million) & (2018-2023)
5.3.5 Qaigen Recent Developments
5.4 Qaigen
5.4.1 Qaigen Profile
5.4.2 Qaigen Main Business
5.4.3 Qaigen NGS-based RNA-seq Products, Services and Solutions
5.4.4 Qaigen NGS-based RNA-seq Revenue (US$ Million) & (2018-2023)
5.4.5 Qaigen Recent Developments
5.5 F. Hoffmann-La Roche
5.5.1 F. Hoffmann-La Roche Profile
5.5.2 F. Hoffmann-La Roche Main Business
5.5.3 F. Hoffmann-La Roche NGS-based RNA-seq Products, Services and Solutions
5.5.4 F. Hoffmann-La Roche NGS-based RNA-seq Revenue (US$ Million) & (2018-2023)
5.5.5 F. Hoffmann-La Roche Recent Developments
5.6 Agilent Technologies
5.6.1 Agilent Technologies Profile
5.6.2 Agilent Technologies Main Business
5.6.3 Agilent Technologies NGS-based RNA-seq Products, Services and Solutions
5.6.4 Agilent Technologies NGS-based RNA-seq Revenue (US$ Million) & (2018-2023)
5.6.5 Agilent Technologies Recent Developments
5.7 Oxford Nanopore Technologies
5.7.1 Oxford Nanopore Technologies Profile
5.7.2 Oxford Nanopore Technologies Main Business
5.7.3 Oxford Nanopore Technologies NGS-based RNA-seq Products, Services and Solutions
5.7.4 Oxford Nanopore Technologies NGS-based RNA-seq Revenue (US$ Million) & (2018-2023)
5.7.5 Oxford Nanopore Technologies Recent Developments
5.8 Perkinelmer
5.8.1 Perkinelmer Profile
5.8.2 Perkinelmer Main Business
5.8.3 Perkinelmer NGS-based RNA-seq Products, Services and Solutions
5.8.4 Perkinelmer NGS-based RNA-seq Revenue (US$ Million) & (2018-2023)
5.8.5 Perkinelmer Recent Developments
5.9 Eurofins Scientific
5.9.1 Eurofins Scientific Profile
5.9.2 Eurofins Scientific Main Business
5.9.3 Eurofins Scientific NGS-based RNA-seq Products, Services and Solutions
5.9.4 Eurofins Scientific NGS-based RNA-seq Revenue (US$ Million) & (2018-2023)
5.9.5 Eurofins Scientific Recent Developments
5.10 Gatc Biotech
5.10.1 Gatc Biotech Profile
5.10.2 Gatc Biotech Main Business
5.10.3 Gatc Biotech NGS-based RNA-seq Products, Services and Solutions
5.10.4 Gatc Biotech NGS-based RNA-seq Revenue (US$ Million) & (2018-2023)
5.10.5 Gatc Biotech Recent Developments
5.11 Macrogen
5.11.1 Macrogen Profile
5.11.2 Macrogen Main Business
5.11.3 Macrogen NGS-based RNA-seq Products, Services and Solutions
5.11.4 Macrogen NGS-based RNA-seq Revenue (US$ Million) & (2018-2023)
5.11.5 Macrogen Recent Developments
6 North America
6.1 North America NGS-based RNA-seq Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe NGS-based RNA-seq Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific NGS-based RNA-seq Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America NGS-based RNA-seq Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa NGS-based RNA-seq Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 NGS-based RNA-seq Market Dynamics
11.1 NGS-based RNA-seq Industry Trends
11.2 NGS-based RNA-seq Market Drivers
11.3 NGS-based RNA-seq Market Challenges
11.4 NGS-based RNA-seq Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
